J Med Genet

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Metcalfe, K. A
Right arrow Articles by Narod, S. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Metcalfe, K. A
Right arrow Articles by Narod, S. A
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
Medline Plus Health Information
*Genetic Counseling
J Med Genet 2000;37:866-874 ( November )

An evaluation of needs of female BRCA1 and BRCA2 carriers undergoing genetic counselling

Kelly A Metcalfea, Alexander Liedea, Elizabeth Hoodfara, Adrienne Scottb, William D Foulkesb, Steven A Naroda

a Centre for Research in Women's Health, University of Toronto, 790 Bay Street, Suite 750A, Toronto, Ontario M5G 1N8, Canada, b Division of Medical Genetics, Department of Medicine, McGill University, Montreal, Quebec H3G 1A4, Canada

Correspondence to: Dr Narod, narod{at}itn.net

Revised version received 26 May 2000; Accepted for publication 5 June 2000

BACKGROUND---The discovery of the breast and ovarian cancer susceptibility genes BRCA1 and BRCA2 has improved our ability to counsel women at increased risk of developing breast and ovarian cancer. The objective of our study was to identify the needs of women who have undergone genetic counselling and testing for BRCA1/2 and to determine the impact of receiving a positive BRCA1/2 result. This is the first study to report on a large group of women who have received positive BRCA1/2 mutation results.
METHODS---Questionnaires were distributed to 105 women who had received pre- and post-test genetic counselling for a positive BRCA1/2 result at the University of Toronto or at McGill University in Montreal, Canada between the years of 1994 and 1998. The questionnaire items included patient motivation for seeking genetic services, information needs, screening and prophylactic surgery practices, satisfaction with access to services and support, the desire for a support group, and overall client satisfaction.
RESULTS---Seventy nine female carriers were surveyed. The majority of the respondents (77%) were satisfied with the information they received during the genetic counselling process. Women with a previous diagnosis of cancer indicated that they needed more information relating to cancer treatment compared to women without cancer (p=0.05). Nineteen percent of the women felt they needed more support than was received. Fifty eight percent of the women reported that their screening practices had changed since they received their result. Young women (below the age of 50) and women with no previous diagnosis of cancer were most likely to have changed their screening practices. Nearly two thirds of the respondents said they had considered prophylactic surgery of the breasts or ovaries. Twenty eight percent of the women had prophylactic mastectomy and 54% had undergone prophylactic oophorectomy. Women with an educational level of high school or more were more likely to have undergone prophylactic bilateral mastectomy than those with less education (p=0.07) but were less likely to undergo prophylactic oophorectomy (p=0.0007).
CONCLUSION---These findings have a direct impact on the counselling and risk management of female BRCA mutation carriers. Age, education, and a previous diagnosis of cancer are important determinants in a woman's decision making after receiving positive genetic test results.


Keywords: genetic counselling; BRCA1; BRCA2; cancer genetics


© 2000 by J Med Genet



This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. H. Halbert, L. Wenzel, C. Lerman, B. N. Peshkin, S. Narod, A. Marcus, C. Corio, T. Demarco, and S. Bellamy
Predictors of Participation in Psychosocial Telephone Counseling following Genetic Testing for BRCA1 and BRCA2 Mutations
Cancer Epidemiol. Biomarkers Prev., May 1, 2004; 13(5): 875 - 881.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
J. Cullen, M. D. Schwartz, W. F. Lawrence, J. V. Selby, and J. S. Mandelblatt
Short-Term Impact of Cancer Prevention and Screening Activities on Quality of Life
J. Clin. Oncol., March 1, 2004; 22(5): 943 - 952.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
D. Braithwaite, J. Emery, F. Walter, A. T. Prevost, and S. Sutton
Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-analysis
J Natl Cancer Inst, January 21, 2004; 96(2): 122 - 133.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
C J van Asperen, S van Dijk, M W Zoeteweij, D R M Timmermans, G H de Bock, E J Meijers-Heijboer, M F Niermeijer, M H Breuning, J Kievit, and W Otten
What do women really want to know? Motives for attending familial breast cancer clinics
J. Med. Genet., June 1, 2002; 39(6): 410 - 414.
[Full Text] [PDF]


Home page
GlycobiologyHome page
Y. Wang, J. Tan, M. Sutton-Smith, D. Ditto, M. Panico, R. M. Campbell, N. M. Varki, J. M. Long, J. Jaeken, S. R. Levinson, et al.
Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis
Glycobiology, December 1, 2001; 11(12): 1051 - 1070.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. Prospero, M. Seminsky, J. Honeyford, B. Doan, E. Franssen, W. Meschino, P. Chart, E. Warner, and M. J. Esplen
Support groups for people carrying a BRCA mutation
Can. Med. Assoc. J., September 1, 2001; 165(6): 740 - 742.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2000 by the BMJ Publishing Group Ltd.